The care routeA reader’s guideOpen the chapters

A chapter for your search

What can I ask about an offer?

Turn broad claims into questions that call for a clear answer. Keep the answers with the written offer.

Ask what the substance actually is

The Food and Drug Administration (FDA) is the US agency that carries out medicine reviews. FDA has found more than one chemical form described by the name BPC-157. It warns that unclear naming can leave a patient with a substance different from the one intended.

  • What is the full ingredient name?
  • Who made the preparation?
  • Which pharmacy would provide it?
  • What rule permits this use of the ingredient?

Ask what a test sheet really shows

A certificate of analysis is a sheet reporting tests on a batch. FDA found that most BPC-157 test sheets it reviewed gave a purity figure but left out limits and test results for unwanted substances. The figure alone did not show which unwanted substances were present or whether their amounts were within limits.

A purity figure can be high while still leaving unanswered whether an injection contains living germs or harmful substances made by bacteria. Those substances, called bacterial toxins, need their own test.

Ask which tests were done on the batch and what those tests leave unanswered. This is a question for the care service, not a home-testing task.

Ask what a badge means

An NDC is a National Drug Code, used to identify a listed drug product. FDA says an NDC does not establish approval.

FDA registration also does not mean a product has approval. These legal records are dated September 26, 2026.

Ask who is there afterward

  • Who answers questions after the assessment?
  • How do I report a problem to the person treating me?
  • What follow-up is included?
  • What happens if I decide not to continue?